Surveillance For New Lung Primaries



Status:Terminated
Conditions:Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:December 2001
End Date:December 2005

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Fluorescence Bronchoscopic Surveillance For New Lung Primaries After Curative Therapy for Squamous Cell Carcinoma of the Aerodigestive Tract"

The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas
in patients with a history of squamous cell cancer of the aerodigestive tract who have been
treated with a curative intent and remain disease free. Detection of pre-invasive and
invasive lesions (moderate to severe dysplasia, CIS) with fluorescence bronchoscopic
surveillance may help to define the natural history of these lesions and allow earlier
intervention should they progress to invasive lesions.


Inclusion Criteria:

- History squamous cell NSCLC who have undergone complete resection or definitive
chemotherapy

Exclusion Criteria:

- History of an aerodigestive tract carcinoma of non-squamous histology

- Patients who have Stage IIIA, IIIB or IV squamous cell lung cancer that have
undergone resection or chemotherapy within three years

- Patients who have Stage I or II squamous cell lung cancer that have undergone
resection or chemotherapy within one year

- Patients who have received external beam radiation therapy for treatment of a
squamous cell cancer of the lung
We found this trial at
1
site
University of Wisconsin Hospital and Clinics
600 Highland Ave
Madison, Wisconsin 53792
(608) 263-6400
University of Wisconsin Hospital and Clinics UW Health strives to meet the health needs of...
?
mi
from
Madison, WI
Click here to add this to my saved trials